Govt amends NDCT Rules 2019 to clarify definition of bioavailability, bioequivalence study centre Medical Dialogues Team7 Sep 2021 10:38 AM GMTNew Delhi: Amending the New Drugs and Clinical Trials Rules, 2019, through a recent gazette notification, the Ministry of Health and Family Welfare (Mo...
Indian vaccines will be effective against COVID-19 variants: ICMR ruchika21 Feb 2021 5:00 AM GMTNew Delhi: The Indian Council of Medical Research (ICMR) on Thursday said interim results of the ongoing clinical trials indicated that the indige...
Alembic Pharma associate firm gets USFDA nod for trial on retroviral oral drug for COVID treatment MD Bureau3 Dec 2020 8:49 AM GMTNew Delhi: Rhizen Pharmaceuticals, an associate company of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regul...
Upadacitinib bests abracept in tough Rheumatoid Arthritis Cases: NEJM study Dr. Nandita Mohan22 Oct 2020 5:27 AM GMTUpadacitinib is an oral selective Janus kinase inhibitor to treat rheumatoid arthritis. The efficacy and safety of upadacitinib as compared with...
Bangladesh declines to approve Chinese COVID vaccine trial by Sinovac Biotech ruchika14 Oct 2020 5:56 AM GMTSinovac Biotech Ltd in a letter on September 24 said the trial would be delayed unless the government provided funds, although the company was...
Biggest challenge in conducting clinical trials is time frame, limitations: NIPER Director ruchika25 Aug 2020 4:00 AM GMTIndustry needs to have a transparency to gain the patient trust and awareness needs to be created through all channels and platforms said by Prof....
Biocon to furnish more data for consideration of Itolizumab in treating COVID patients Farhat Nasim29 July 2020 10:54 AM GMTBengaluru: After facing rejection from the Health Ministry, Bengaluru-based drugmaker Biocon is now preparing to present 'more data' for consideration ...
Setback to Biocon: Health Ministry Says NO To Psoriasis Drug Itolizumab In Clinical Management Protocols For COVID-19 ruchika27 July 2020 10:29 AM GMTNew Delhi: In a major setback to drug major, Biocon, the National Task Force on COVID-19 has decided against including Itolizumab drug in clinical mana...
CONTROVERSY: DCGI exempts Biocon from Phase 3 trial of COVID drug Itolizumab, ICMR sees red Farhat Nasim17 July 2020 10:51 AM GMTBengaluru: In a major controversy, the exemption of biotechnology major Biocon from conducting Phase 3 trials of its psoriasis drug Itolizuma...
Zydus Cadila starts human trails of COVID-19 vaccine ZyCoV-D ruchika16 July 2020 7:14 AM GMTSpeaking on the development, Chairman, Zydus Cadila, Mr. Pankaj R. Patel said, 'This is an all-important step in our fight against COVID-19. We...
